Published in TB and Outbreaks Week, July 22nd, 2003
In a study from Spain, "early reconstitution of lymphoid populations was monitored by immunophenotyping in 57 allogeneic peripheral blood stem cell (allo-PBSC) transplant patients" with or without CMV "viremia or disease."
"Cell counts for total lymphocytes and CD4+ T cells above the percentile 60th at day 14 postransplant were associated significantly with CMV viremia-free survival within 120 days after transplant," according to A. Gutierrez and coauthors at the University of Valencia.
"Recovery of total...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.